Ashly Skaggs
Psychiatric/Mental Health · Owensboro, KYNPI 1902511462
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 430 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in KY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 430 payments — averaging $16.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- AbbVie$877
- Otsuka America Pharmaceutical, Inc.$705
- Teva Pharmaceuticals USA, Inc.$577
- Neurocrine Biosciences, Inc.$490
- Axsome Therapeutics, Inc.$433
- plus $3K from 15 others
What the payments were for
- Food & beverage$6,937100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 72 | $1,045 |
| AbbVie | 66 | $877 |
| Otsuka America Pharmaceutical, Inc. | 47 | $705 |
| Teva Pharmaceuticals USA, Inc. | 32 | $577 |
| Neurocrine Biosciences, Inc. | 25 | $490 |
| Axsome Therapeutics, Inc. | 25 | $433 |
| Alkermes, Inc. | 27 | $428 |
| Corium, LLC | 33 | $425 |
| Vanda Pharmaceuticals Inc. | 16 | $343 |
| Biogen | 12 | $305 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $271 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $269 |
| Lundbeck LLC | 14 | $246 |
| E.r. Squibb & Sons, L.L.C. | 16 | $183 |
| Noven Therapeutics, LLC | 8 | $148 |
| Tris Pharma Inc | 3 | $51 |
| Ironshore Pharmaceuticals Inc. | 2 | $40 |
| Collegium Pharmaceutical, Inc. | 2 | $35 |
| Idorsia Pharmaceuticals US Inc | 2 | $31 |
| Indivior Inc. | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$125
How this compares
$6,937 in reported general payments places this provider in the 90th percentile of 946 psychiatric/mental health providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trazodone Hcl | 11 | $73 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Owensboro
- Tiffany YocumOwensboro$11K
- Melanie StanishiaOwensboro$8K
- Megan PhillipsOwensboro$8K
- Theresa WattsAshland$645K
- Rachel ColeHopkinsville$503K
- Denise de AngelisLouisville$384K
- Jennifer SampangCrestview Hills$322K
- Jeremy FisherSouth Shore$197K
- Jessica EstesLewisport$175K
- Christopher MulloneyNancy$95K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.